Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Idalopirdine

Generic Name: Idalopirdine

Drug Type: Small Molecule

Chemical Formula: C_₂₀H_₁₉F_₅N_₂O

CAS Number: 467459-31-0

Unique Ingredient Identifier: 59WCJ0YNWM

Overview

Idalopirdine has been used in trials studying the treatment of Cognition, Schizophrenia, and Alzheimer's Disease.

Background

Idalopirdine has been used in trials studying the treatment of Cognition, Schizophrenia, and Alzheimer's Disease.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Positron Emission Tomography (PET) Study in Patients With Alzheimer's Disease

Phase 1

Terminated

Posted: 2017/10/12

Sponsor:H. Lundbeck A/S

ID:NCT03307993

Bioequivalence Study of Idalopirdine in Healthy Subjects

Phase 1

Withdrawn

Posted: 2016/09/09

Sponsor:H. Lundbeck A/S

ID:NCT02894515

Study Investigating the Effect of Idalopirdine on Cardiac Repolarisation in Healthy Men

Phase 1

Completed

Posted: 2015/05/06

Sponsor:H. Lundbeck A/S

ID:NCT02436486

Bioequivalence Study of Idalopirdine Tablets 60 mg

Phase 1

Completed

Posted: 2015/02/26

Sponsor:H. Lundbeck A/S

ID:NCT02371707

Pharmacokinetic Properties of Idalopirdine (Lu AE58054) in Subjects With and Without Impaired Kidney Function

Phase 1

Completed

Posted: 2015/01/16

Sponsor:H. Lundbeck A/S

ID:NCT02340195

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy